These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34155787)

  • 1. HBV 2021: New therapeutic strategies against an old foe.
    Roca Suarez AA; Testoni B; Zoulim F
    Liver Int; 2021 Jun; 41 Suppl 1():15-23. PubMed ID: 34155787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy for chronic hepatitis B: a review.
    Hanazaki K
    Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):63-70. PubMed ID: 15032642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis B Virus Infection: Current Trends and Issues].
    Furusyo N; Shimizu M; Ogawa E; Murata M; Hayashi J
    Rinsho Byori; 2015 Jun; 63(6):755-61. PubMed ID: 26548241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    ;
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma.
    Zhou Q; Zhang Q; Wang K; Huang T; Deng S; Wang Y; Cheng C
    Pharmacol Res; 2022 Apr; 178():106181. PubMed ID: 35301112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.
    Tawada A; Kanda T; Imazeki F; Yokosuka O
    Hepatol Int; 2016 Jul; 10(4):574-93. PubMed ID: 27026375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.
    Zhang YQ; Guo JS
    World J Gastroenterol; 2015 Apr; 21(13):3860-6. PubMed ID: 25852270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
    Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM
    BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy.
    Battistella S; Lynch EN; Gambato M; Zanetto A; Pellone M; Shalaby S; Sciarrone SS; Ferrarese A; Germani G; Senzolo M; Burra P; Russo FP
    Minerva Gastroenterol (Torino); 2021 Mar; 67(1):38-49. PubMed ID: 33222431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.
    Wei Q; Xu X; Ling Q; Zhou B; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):251-5. PubMed ID: 23742769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma.
    Ailioaie LM; Litscher G
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of the study of hepatitis B virus covalently closed circular DNA.
    Kumar R; Pérez-Del-Pulgar S; Testoni B; Lebossé F; Zoulim F
    Liver Int; 2016 Jan; 36 Suppl 1():72-7. PubMed ID: 26725901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in antivirals against hepatitis B virus.
    Wang YJ; Yang L; Zuo JP
    Virus Res; 2016 Feb; 213():205-213. PubMed ID: 26732483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus.
    Kim SW; Yoon JS; Lee M; Cho Y
    Clin Mol Hepatol; 2022 Jan; 28(1):17-30. PubMed ID: 34281294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study.
    Chang Y; Choe WH; Sinn DH; Lee JH; Ahn SH; Lee H; Shim JJ; Jun DW; Park SY; Nam JY; Cho EJ; Yu SJ; Lee DH; Lee JM; Kim YJ; Kwon SY; Paik SW; Yoon JH
    J Infect Dis; 2017 Dec; 216(11):1407-1414. PubMed ID: 29029102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antiviral therapy in the management of hepatocellular carcinoma.
    Guan YS; He Q
    Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
    Lok AS
    J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.